Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
36.46
0.00 (0.00%)
At close: Nov 13, 2026, 4:00 PM EST
36.46
-0.01 (-0.01%)
After-hours: Nov 13, 2026, 7:30 PM EST
Pacira BioSciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 246.96 | 158.55 | 276.77 | 153.3 | 104.14 | 585.58 |
Short-Term Investments | 48.62 | 79.88 | 207.84 | 125.28 | 184.51 | 70.83 |
Cash & Short-Term Investments | 295.58 | 238.42 | 484.62 | 278.58 | 288.65 | 656.41 |
Cash Growth | 19.99% | -50.80% | 73.96% | -3.49% | -56.03% | 25.83% |
Accounts Receivable | 122.89 | 124.07 | 113.3 | 105.56 | 98.4 | 96.32 |
Other Receivables | 8 | 0.3 | 0.5 | 0.4 | 0.8 | 0.1 |
Receivables | 130.89 | 124.37 | 113.8 | 105.96 | 99.2 | 96.42 |
Inventory | 129.49 | 152.86 | 125.28 | 104.35 | 96.06 | 98.55 |
Prepaid Expenses | 34.26 | 30.62 | 20.43 | 20.4 | 14.32 | 14.67 |
Other Current Assets | - | 1.7 | 1 | 0.7 | 0.1 | - |
Total Current Assets | 590.23 | 547.97 | 745.13 | 509.99 | 498.33 | 866.05 |
Property, Plant & Equipment | 171.64 | 182.47 | 216.39 | 234.95 | 254.39 | 264.81 |
Long-Term Investments | 20.44 | 16.31 | 29.45 | 32.26 | 60.18 | 21.99 |
Goodwill | 19.54 | 20.21 | - | 163.24 | 163.24 | 145.18 |
Other Intangible Assets | 273 | 368.1 | 425.97 | 483.26 | 540.55 | 623.97 |
Long-Term Deferred Tax Assets | 125.31 | 123.85 | 130.38 | 144.49 | 160.31 | 153.36 |
Other Long-Term Assets | - | 6 | 6.2 | 6.2 | 4.2 | - |
Total Assets | 1,203 | 1,265 | 1,554 | 1,574 | 1,681 | 2,075 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 17.51 | 15.15 | 19.13 | 15.7 | 15.22 | 10.54 |
Accrued Expenses | 85.93 | 84.05 | 69.52 | 55.72 | 82.49 | 118.6 |
Current Portion of Long-Term Debt | - | - | 201.78 | 8.64 | 33.65 | 374.7 |
Current Portion of Leases | 10.09 | 9.84 | 8.89 | 8.8 | 9.12 | 7.89 |
Current Income Taxes Payable | - | - | - | - | - | 0.43 |
Other Current Liabilities | 12.58 | 11.55 | 10.61 | 8.53 | 7.3 | 8.95 |
Total Current Liabilities | 126.1 | 120.59 | 309.92 | 97.38 | 147.77 | 521.12 |
Long-Term Debt | 293.59 | 372.19 | 383.55 | 513.8 | 655.82 | 674.53 |
Long-Term Leases | 36.6 | 36.18 | 44.65 | 54.81 | 64.8 | 71.73 |
Long-Term Deferred Tax Liabilities | 4.03 | 4.21 | - | - | - | - |
Other Long-Term Liabilities | 30 | 38.64 | 37.06 | 38.27 | 37.79 | 77.57 |
Total Liabilities | 490.32 | 571.81 | 775.17 | 704.26 | 906.19 | 1,345 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Additional Paid-In Capital | 1,100 | 1,065 | 1,009 | 976.63 | 924.1 | 942.09 |
Retained Earnings | -163.23 | -199.32 | -206.36 | -106.8 | -148.75 | -211.9 |
Treasury Stock | -227.01 | -176.57 | -25.12 | - | - | - |
Comprehensive Income & Other | 3.01 | 4.33 | 0.34 | 0.25 | -0.38 | 0.17 |
Shareholders' Equity | 712.32 | 693.11 | 778.35 | 870.13 | 775.01 | 730.41 |
Total Liabilities & Equity | 1,203 | 1,265 | 1,554 | 1,574 | 1,681 | 2,075 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 340.28 | 418.2 | 638.85 | 586.04 | 763.39 | 1,129 |
Net Cash (Debt) | -44.7 | -179.78 | -154.24 | -307.46 | -474.74 | -472.44 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.07 | -3.99 | -3.34 | -5.92 | -10.20 | -10.35 |
Filing Date Shares Outstanding | 40.09 | 40.49 | 46.28 | 46.5 | 45.95 | 44.85 |
Total Common Shares Outstanding | 39.9 | 41.12 | 46.24 | 46.48 | 45.93 | 44.73 |
Working Capital | 464.13 | 427.38 | 435.21 | 412.61 | 350.56 | 344.93 |
Book Value Per Share | 17.85 | 16.86 | 16.83 | 18.72 | 16.87 | 16.33 |
Tangible Book Value | 419.79 | 304.8 | 352.38 | 223.63 | 71.22 | -38.74 |
Tangible Book Value Per Share | 10.52 | 7.41 | 7.62 | 4.81 | 1.55 | -0.87 |
Machinery | 192.8 | 191.46 | 186.07 | 141.5 | 136.46 | 133.34 |
Construction In Progress | 15.79 | 9.49 | 28 | 105.91 | 103.23 | 80.56 |
Leasehold Improvements | 78.38 | 77.45 | 86.03 | 61.83 | 61.3 | 59.74 |